S&P 500 Futures
(0.25%) 5 144.25 points
Dow Jones Futures
(0.23%) 38 530 points
Nasdaq Futures
(0.34%) 17 907 points
Oil
(-0.44%) $83.48
Gas
(1.98%) $1.961
Gold
(0.00%) $2 347.30
Silver
(0.30%) $27.62
Platinum
(0.81%) $929.55
USD/EUR
(-0.20%) $0.933
USD/NOK
(-0.30%) $10.99
USD/GBP
(-0.29%) $0.798
USD/RUB
(1.14%) $92.92

实时更新: Pacira Biosciences Inc [PCRX]

交易所: NASDAQ 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 9.40%

BUY
33.33%
return -7.65%
SELL
33.33%
return -2.77%
最后更新时间27 Apr 2024 @ 04:00

3.25% $ 26.33

购买 108732 min ago

@ $29.13

发出时间: 14 Feb 2024 @ 03:52


回报率: -9.62%


上一信号: Feb 13 - 23:58


上一信号: 出售


回报率: -1.81 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):
Profile picture for Pacira Biosciences Inc

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States...

Stats
今日成交量 287 074
平均成交量 501 528
市值 1.22B
EPS $0 ( 2024-02-29 )
下一个收益日期 ( $0.650 ) 2024-05-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 29.58
ATR14 $0.0190 (0.07%)
Insider Trading
Date Person Action Amount type
2024-03-06 Pace Gary W Sell 1 066 Common Stock
2024-03-07 Pace Gary W Sell 28 257 Common Stock
2024-03-08 Pace Gary W Sell 90 000 Common Stock
2024-02-05 Williams Kristen Buy 33 700 Common Stock
2024-02-05 Gaugler Daryl Buy 33 700 Common Stock
INSIDER POWER
58.65
Last 95 transactions
Buy: 1 581 500 | Sell: 429 616

音量 相关性

長: 0.28 (neutral)
短: 0.60 (weak)
Signal:(62.503) Neutral

Pacira Biosciences Inc 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Pacira Biosciences Inc 相关性 - 货币/商品

The country flag 0.10
( neutral )
The country flag 0.15
( neutral )
The country flag 0.00
( neutral )
The country flag 0.24
( neutral )
The country flag -0.07
( neutral )
The country flag 0.00
( neutral )

Pacira Biosciences Inc 财务报表

Annual 2023
营收: $674.98M
毛利润: $433.02M (64.15 %)
EPS: $0.910
FY 2023
营收: $674.98M
毛利润: $433.02M (64.15 %)
EPS: $0.910
FY 2022
营收: $666.82M
毛利润: $467.53M (70.11 %)
EPS: $0.350
FY 2021
营收: $541.53M
毛利润: $401.28M (74.10 %)
EPS: $0.944

Financial Reports:

No articles found.

Pacira Biosciences Inc

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。